Orphazyme: Preparation in progress for filing in 2020
Orphazyme today announced, based on feedback from the European Medical Agency (EMA), that they are preparing for filing with arimoclomol in Niemann-Pick Disease Type C (NPC). We acknowledge this press release as confirmatory to our timeline.